title: The changing role of imaging in clinical care.
abstract: Considerable developments in prostate cancer in 2013 have emerged from the imaging field. Hyperpolarized 13C-MRI can monitor metabolic activity to identify high-grade disease and treatment response, and novel PET radiotracers might identify distinct subsets of patients with advanced disease. These examples highlight the progress made at all stages of care.
authors.affiliation: Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, 1600 Divasadero Street, Room A717, Box 1711, San Francisco, CA 94115, USA.
authors.forename: Rahul
authors.initials: R
authors.lastname: Aggarwal
authors.affiliation: Departments of Medicine and Radiology and Biomedical Imaging, University of California, San Francisco, 1700 4th Street, Byers Hall, Room 203, San Francisco, CA 94158, USA.
authors.forename: John
authors.initials: J
authors.lastname: Kurhanewicz
mesh_terms: D003952:Diagnostic Imaging; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy*